Citi lowered the firm’s price target on Incyte (INCY) to $88 from $97 and keeps a Buy rating on the shares. The company reported Q4 results, ...

TD Cowen analyst Marc Frahm raised the firm’s price target on Incyte (INCY) to $88 from $86 and keeps a Buy rating on the shares. The firm said ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Shares of Incyte Corp. INCY slid 1.09% to $74.13 Friday, on what proved to be an all-around poor trading session for the ...

After hours: February 7 at 7:56:10 PM EST Loading Chart for INCY ...

Incyte has a 12 month low of $50.35 and a 12 month high of $83.95. The company has a current ratio of 1.87, a quick ratio of 1.82 and a debt-to-equity ratio of 0.01. Insider Activity at Incyte ...

WILMINGTON, Del., February 07, 2025--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 16,301 shares of the ...

A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata. In a brief filing with the National Stock Exchange (NSE ...